Skip to content

Fruzaqla

Published: July 26, 2026Updated: July 26, 2026

Fruzaqla (fruquintinib) is a prescription medication used to treat adults with metastatic colorectal cancer that has progressed after prior chemotherapy treatment. It belongs to a class of drugs called kinase inhibitors that target specific pathways involved in cancer growth.

Quick summary

Fruzaqla is a targeted therapy for metastatic colorectal cancer that has returned or spread after other treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
2670185
Generic
Fruzaqla
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Fruzaqla is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, anti-VEGF therapy, and, if RAS wild-type and medically appropriate, anti-EGFR therapy.

Fruzaqla is a vascular endothelial growth factor receptor (VEGFR) inhibitor that works by blocking the activity of specific tyrosine kinases involved in tumor angiogenesis (formation of new blood vessels that feed tumors) and tumor progression.

Common side effects may include hypertension, fatigue, hand-foot syndrome, and proteinuria. Patients should have blood pressure monitored regularly during treatment. Fruzaqla may cause fetal harm; pregnancy should be avoided during treatment. This is a brand-name medication and should only be used as prescribed by a healthcare provider.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy